$TRXB SEC Filings

Filed On	Filing
16 Oct 2026	SCHEDULE 13G
16 Oct 2026	SCHEDULE 13D
16 Oct 2026	SCHEDULE 13D
15 Oct 2026	Form 4: Alexandria Venture Investments, Llc, 10% owner Received 1,167,930 shares by conversion · Bought 178,571 shares ($2.5M)
15 Oct 2026	SCHEDULE 13G
13 Oct 2026	Form 4: Marcus Joel S, Director Received 41,871 shares by conversion
13 Oct 2026	Form 4: Svlsf VI, Llc, 10% owner and 2 others Bought 92,857 shares ($1.3M) · Received 2,789,593 shares by conversion
13 Oct 2026	8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year An annual meeting of the stockholders of TRex Bio, Inc., a Delaware corporation (the “Corporation”), for the election of directors to succeed those whose terms expire and for the transaction of such other business as may properly come be...
09 Oct 2026	S-8
09 Oct 2026	424B4
08 Oct 2026	Form 3: Kelman Ariella, Chief Medical Officer
08 Oct 2026	Form 3: Eli Lilly & Co, 10% owner Holds 5,480,872 shares of Common Stock
08 Oct 2026	Form 3: Svlsf VI, Llc, 10% owner and 2 others Holds 4,282 shares of Common Stock
08 Oct 2026	Form 3: Alexandria Venture Investments, Llc, 10% owner
08 Oct 2026	Form 4: Marcus Joel S, Director Granted 17,500 Stock Option (Right to Buy)
08 Oct 2026	Form 4: Coy Travis Alan, Director Granted 17,500 Stock Option (Right to Buy)
08 Oct 2026	Form 4: Ross Michael Jay, Director Granted 17,500 Stock Option (Right to Buy)
08 Oct 2026	Form 4: Hirth Peter, Director Granted 17,500 Stock Option (Right to Buy)
08 Oct 2026	Form 4: Gallagher Carol Giltner, Director Granted 17,500 Stock Option (Right to Buy)
08 Oct 2026	Form 4: Gilmore Julie Ann, Director Granted 17,500 Stock Option (Right to Buy)

Comments